Doxonil
Doxonil Products are primarily used for
About Doxonil Products
Uses of Doxonil Products
Doxofylline is used in the treatment and prevention of chronic obstructive pulmonary disease and asthma.
Doxonil Products side effects
Common
Side Effects of Doxonil are Headache, Nausea1a, Vomiting, Insomnia (difficulty in sleeping), Epigastric pain, Irritability, Tachycardia.
How Doxonil Products work
Doxofylline is a bronchodilator. It works by relaxing the muscles of the airways and widens airways. This makes breathing easier.
Patient Concerns about Doxonil Products
Frequently asked questions about Doxonil Products
Frequently asked questions about Doxofylline
Q. What is Doxonil 400 Tablet?
Doxonil 400 Tablet is a new generation long-acting oral bronchodilator. It is a methyxanthine derivative.
Q. How does Doxonil 400 Tablet work?
Doxonil 400 Tablet inhibits an enzyme called phosphodiesterase which results in bronchodilation (dilation or widening of the airways in the lungs by relaxing the surrounding smooth muscle). It is used for the treatment of asthma and chronic obstructive pulmonary disease (COPD). COPD is a lung disease characterized by chronic obstruction of lung airflow that interferes with normal breathing and is not fully reversible. Doxonil 400 Tablet relieves the breathlessness and cough thereby providing symptomatic relief.
Q. Is Doxonil 400 Tablet antibiotic?
Doxonil 400 Tablet is not an antibiotic. Doxonil 400 Tablet is a bronchodilator used for the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Q. Is Doxonil 400 Tablet a steroid?
Doxonil 400 Tablet is not a steroid. Doxonil 400 Tablet is a bronchodilator used for the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Q. What is Doxonil 400 Tablet used for?
Doxonil 400 Tablet is a bronchodilator used for the treatment of asthma and chronic obstructive pulmonary disease (COPD). It helps to relieve breathlessness and cough thereby providing symptomatic relief.
Products for Doxonil
₹62
7% off
MRP
₹67
Not Available